PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,010,106 | -15.0% | 180,462 | +40.8% | 0.02% | -8.0% |
| Q2 2023 | $3,540,801 | +35.8% | 128,197 | +13.1% | 0.02% | +25.0% |
| Q1 2023 | $2,607,165 | -0.7% | 113,355 | -52.9% | 0.02% | 0.0% |
| Q4 2022 | $2,626,528 | +28.2% | 240,745 | -0.9% | 0.02% | +17.6% |
| Q3 2022 | $2,049,000 | +125.7% | 243,013 | +111.8% | 0.02% | +142.9% |
| Q2 2022 | $908,000 | -68.0% | 114,759 | -4.2% | 0.01% | -61.1% |
| Q1 2022 | $2,838,000 | -30.1% | 119,834 | +0.9% | 0.02% | -30.8% |
| Q4 2021 | $4,060,000 | +221.2% | 118,715 | +66.4% | 0.03% | +188.9% |
| Q3 2021 | $1,264,000 | -76.4% | 71,343 | -40.2% | 0.01% | -74.3% |
| Q2 2021 | $5,358,000 | – | 119,391 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |